Efficacy, Safety, and Economics of Innovative Medicines: The Role of Multi-Criteria Decision Analysis and Managed Entry Agreements in Practice and Policy

Through the years, solutions for accelerated access to innovative treatments are implemented in models of regulatory approvals, yet with limited data. Besides efficacy data, providing adequate safety data is key to transferring conditional marketing authorization to final marketing authorization. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Fens, Tanja, van Puijenbroek, Eugène P., Postma, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medical Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757864/
https://www.ncbi.nlm.nih.gov/pubmed/35047908
http://dx.doi.org/10.3389/fmedt.2021.629750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757864/
https://www.ncbi.nlm.nih.gov/pubmed/35047908
http://dx.doi.org/10.3389/fmedt.2021.629750

Ejemplares similares